CD22 (RFB-4) PE Antibody sc-7307 PE from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

CD22 (RFB-4) PE Antibody

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
CD22 (RFB-4) PE Antibody

The CD22 (RFB-4) PE Antibody from Santa Cruz Biotechnology, Inc. is a Mouse Monoclonal antibody to CD22. This antibody recognizes Homo Sapiens, and Human antigen. The CD22 (RFB-4) PE Antibody has been shown to work in the following applications: Flow Cytometry, Immunofluorescence, Immunohistochemistry - fixed, and Western Blot.

Product Specs
ItemCD22 (RFB-4) PE Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $343.00Supplier Page View Company Product Page
Catalog Numbersc-7307 PE
Antibody TypePrimary Antibody Conjugates
Clonalitymonoclonal
Reactivityhuman
FormatPurified
ApplicationsWB(RGB), IF, IHC(P), FCM
CloneRFB-4
IsotypeIgG1
Hostmouse
Quantity200 µg/ml
TargetCD22
NCBI Full Gene NameCD22 molecule
NCBI Gene AliasesSIGLEC-2, SIGLEC2
Conjugate/Tagphycoerythrin

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Antitumor efficacy of a combination of CMC-544 (inotuzumab ozogamicin), a CD22-targeted cytotoxic immunoconjugate of calicheamicin, and rituximab against non-Hodgkin's B-cell lymphomaClinical cancer research : an official journal of the American Association for Cancer ResearchJanuary 1, 2006DiJoseph JF, Dougher MM, Kalyandrug LB, Armellino DC, Boghaert ER, Hamann PR, Moran JK, Damle NK.

(2) Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22Cancer immunology, immunotherapy : CIIJanuary 1, 2005DiJoseph JF, Popplewell A, Tickle S, Ladyman H, Lawson A, Kunz A, Khandke K, Armellino DC, Boghaert ER, Hamann P, et al.

Be the First to Write a Review!